MAPRx Responds to Congressional Drug Pricing Efforts

Earlier today, the MAPRx Coalition and 27 of its member organizations submitted letters to House and Senate leadership in response to the ongoing congressional efforts to address drug pricing and affordability.

Specifically, the letters urged congressional leaders to focus on the following policies to improve the beneficiary experience in Medicare Part D:

• Create an out-of-pocket (OOP) cap on Medicare Part D costs with a monthly cap on total OOP (smoothing);
• Manage any unintended consequences of legislative changes proactively so that beneficiary access is maintained both in the short-term (formularies, pharmacy networks, limited utilization management) and long-term (continued access to therapies);
• Reform the Part D exceptions and appeals process;
• Strengthen the Low-Income Subsidy (LIS) program;
• Eliminate cost-sharing for Part D vaccines;
• Improve information and consumer education for Part D beneficiaries.

To read the complete letter submitted to House leadership, click here. The Senate version of the letter is available here (letter content is identical).